Cellectis (CLLS) Long-Term Investments (2019 - 2026)

Cellectis (CLLS) recorded quarterly Long-Term Investments of $4.8 million in Q1 2026, down 5.27% quarter-over-quarter from $5.1 million in Q4 2025, and down 8.4% on a YoY basis from $5.3 million in Q1 2025.

Cellectis (CLLS) Long-Term Investments (2019 - 2026) Analysis & Trends

Cellectis' Long-Term Investments history runs 8 years deep, the most recent figure standing at $4.8 million for Q1 2026.

  • In Q1 2026, Long-Term Investments fell 8.4% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 8.4% YoY), while the FY2025 annual figure was $5.1 million, down 32.35% from the prior year.
  • Long-Term Investments was $4.8 million for Q1 2026 at Cellectis, down from $5.1 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $35.7 million in Q3 2025 to a low of $4.8 million in Q1 2026.
  • Historically, Long-Term Investments has averaged $12.0 million across 5 years, with a median of $8.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Long-Term Investments surged 710.0% in 2022, then slumped 53.98% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $8.1 million in 2022, then retreated by 3.05% to $7.9 million in 2023, then decreased by 4.23% to $7.5 million in 2024, then tumbled by 32.35% to $5.1 million in 2025, then decreased by 5.27% to $4.8 million in 2026.
  • The last three Long-Term Investments figures came in at $4.8 million (Q1 2026), $5.1 million (Q4 2025), and $35.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cellectis 17.40 Bn 17.21 Bn - 4.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.82 Mn
Dec 31, 2025 5.09 Mn
Sep 30, 2025 35.74 Mn
Jun 30, 2025 35.49 Mn
Mar 31, 2025 5.26 Mn
Dec 31, 2024 7.52 Mn
Sep 30, 2024 7.65 Mn
Jun 30, 2024 16.65 Mn
Mar 31, 2024 7.87 Mn
Dec 31, 2023 7.85 Mn
Sep 30, 2023 16.62 Mn
Jun 30, 2023 13.01 Mn
Mar 31, 2023 8.19 Mn
Dec 31, 2022 8.10 Mn
Sep 30, 2022 8.93 Mn
Jun 30, 2022 9.09 Mn
Mar 31, 2022 6.57 Mn
Dec 31, 2021 1.00 Mn
Dec 31, 2020 1.00 Mn
Dec 31, 2019 5.00 Mn